Federal Register Notice: FDA is amending the Emergency Use Authorization (EUA) for doxycycline hyclate tablet emergency kits for eligible U.S. Postal Service participants in the Cities Readiness Initiative (CRI) and their household members issued 10/3/08. On 4/8 the Biomedical Advanced Research and Development Authority submitted a request to further amend the authorization to reflect certain programmatic changes, including replacing references to the CRI with the National Postal Model. To view this notice, click here.